Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (22)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by BULBULYAN, M. A
Right arrow Articles by ZARIDZE, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BULBULYAN, M. A
Right arrow Articles by ZARIDZE, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 Oxford University Press

research-article

Cancer Incidence and Mortality among Beta-Naphthylamine and Benzidine Dye Workers in Moscow

MARIANA A BULBULYAN*, LARRY W FIGGS{dagger},, SHEILA HOAR ZAHM{dagger}, TATYANA SAVITSKAYA*, ALEXANDER GOLDFARB*, SERGEI ASTASHEVSKY* and DAVID ZARIDZE*

* Unit of Occupational Cancer Epidemiology, Department of Cancer Epidemiology and Prevention, Institute of Carcinogenesis, N N Blokhin Cancer Research Centre Moscow, Russia.
{dagger} Occupational Studies Section. Environmental Epidemiology Branch. Epidemiology and Biostatistics Program, National Cancer Institute Executive Plaza North, Room 418, Rockville, MD 20892, USA.

Reprint requests to: Dr L W Figgs.

Background. Cancer incidence and mortality were evaluated among 4581 aniline dye production workers in Moscow. Methods. A historical cohort was assembled and followed-up from 1 January 1975 to 31 December 1989. Moscow district oncologic dispensary registries furnished case ascertainment and employer records provided job exposure data. Expected cancers and deaths were calculated based on gender-, age-, and calendar time-specific incidence and mortality rates for the Moscow general population applied to the cohort's person-years of follow-up. Disease-specific standardized mortality and incidence values were derived from ratios of observed to expected cancers.

Results. Men experienced elevated total cancer mortality (standardized mortality ratio [SMR] = 125; 95% Cl: 110–142) and urinary bladder cancer mortality (SMR = 279, 95% Cl: 192–391), and increased all malignancy (standardized incidence ratio [SIR] = 142; 95% Cl. 125–160), oesophageal (SIR = 203; 95% Cl 108–347), respiratory tract (SIR = 154; 95% Cl: 120–194) and bladder (SIR = 394; 95% Cl: 268–559) cancer incidence Women had elevated oesophageal (SMR = 313; 95% Cl. 124–664) and bladder (SMR = 311; 95% Cl: 149–571) cancer mortality and elevated all malignancy (SIR = 124; 95% Cl: 106–144), oesophageal (SIR = 348; 95% Cl: 140–719), and bladder (SIR = 861; 95% Cl: 458–8002) cancer incidence. Bladder cancer rate increased with employment duration and younger age first hired. Rate estimates were highest among beta-naphthylamine exposed workers but was also increased among workers with other chemical exposures. A cancer prevention and control effort that limited benzidine exposure to <3 years was apparently unsuccessful as indicated by a significant excess of bladder cancer (SIR = 1773; 95% Cl: 356–5180) among these workers.

Conclusion. Relative rates of oesophageal, lung and stomach cancer were also elevated among all workers, but did not increase with total years worked, age first hired, or year first hired, suggesting a non-occupational aetiology.

Received 1 October 1994


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol Ind HealthHome page
S. R. Ostrowski, S. Wilbur, C.-H. S. J. Chou, H. R. Pohl, Y.-W. Stevens, P. M. Allred, N. Roney, M. Fay, and C. A. Tylenda
Agency for Toxic Substances and Disease Registry's 1997 priority list of hazardous substances. Latent effects--carcinogenesis, neurotoxicology, and developmental deficits in humans and animals
Toxicology and Industrial Health, August 1, 1999; 15(7): 602 - 644.
[Abstract] [PDF]


Home page
JAMAHome page
S. H. Zahm, L. W. Figgs, M. Bulbulyan, and D. G. Zaridze
Genetic Polymorphisms and Breast Cancer Risk
JAMA, February 19, 1997; 277(7): 533 - 534.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.